On Monday, December 9, the next meeting of the Transparency Council.
The agenda includes:
1 Prepare a position paper on the qualification of the M-Typer health care service for the diagnosis of mycobacteriosis and other mycobacterioses.
2 Prepare a position paper on the evaluation of the drug Vabinxo (valsartanum + indapamidum) for the indication: treatment of spontaneous hypertension, as substitution treatment in adult patients adequately controlled with valsartan and indapamide administered simultaneously at the same dose as in combination, but in the form of separate tablets.
